Thermo Fisher Scientific Inc TMO
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1980-08-27 |
| Shares Out. | 371,620,000 |
| Website | corporate.thermofisher.com/us/en/index.html ↗ |
| Phone | 17816221000 |
| Employees | 125,000 |
| Revenue | $11.99B |
| Gross Profit | $4.88B |
| Net Income | $1.74B |
| Free Cash Flow | $7.32B |
| Total Assets | $113.17B |
| Total Liabilities | $60.37B |
| Equity | $52.69B |
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Thermo Fisher Scientific Inc is a publicly traded company under the ticker symbol TMO on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
36 analysts (2026-09-01)

